Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.453
Buy
RSI(14)
71.390
Buy
STOCH(KDJ)(9,3,3)
66.484
Neutral
ATR(14)
1.401
High Vlolatility
CCI(14)
307.499
Overbought
Williams %R
34.268
Buy
TRIX(12,20)
0.469
Sell
StochRSI(14)
100.000
Buy
Search
Castle Biosciences Inc
CSTLAdd to Watchlist
28.090USD
+1.300+4.85%
Close 07-31 16:00（ET）Quotes delayed by 15 min
856.98MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+4.85%
5 Days
+13.79%
1 Month
+17.78%
6 Months
-28.69%
Year to Date
-27.79%
1 Year
+85.41%
Key Figures
28.800Open
30.810High
1.76MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
5.76%Turnover Ratio
26.790Prev. Close
27.500Low
29.55MTurnover
46.97P/E Static
1.82P/B
0.00%Div Yield TTM
-2.45%ROA
44.28052wk High
4.14Volume Ratio
18.25MNet Profit
30.51MShares
-0.4158EPS TTM
1.07Beta
-2.85%ROE
14.59052wk Low
12.36%Amplitude
74.94%Gross Margin
856.98MMarket Cap
3.54Reward/Risk
3.14%Risk Rate
TradingKey Stock Score of Castle Biosciences Inc
Currency: USD Updated: 2026-07-31Key Insights
Castle Biosciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 2 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 42.78.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Castle Biosciences Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Castle Biosciences Inc Highlights
StrengthsRisks
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers five commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology and ophthalmology. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for use in patients with cutaneous squamous cell carcinoma (SCC). It also focused on chronic acid reflux related diseases, including esophageal cancer.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 56.62% year-on-year.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -67.34, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 27.62M shares, decreasing 6.13% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 29.58K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.28.
Analyst Rating
Based on
9
analysts
Strong Buy
Current Rating
42.778
Target Price
+74.89%
Upside Space
Castle Biosciences Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Strong Buy
Current Rating
42.778
Target Price
+74.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Castle Biosciences Inc
CSTL
9
Medtronic PLC
MDT
33
Zimmer Biomet Holdings Inc
ZBH
31
Dexcom Inc
DXCM
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
25.516
Buy
MA10
25.096
Buy
MA20
24.472
Buy
MA50
22.667
Buy
MA100
23.235
Buy
MA200
28.865
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Castle Biosciences Inc Info
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers five commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology and ophthalmology. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for use in patients with cutaneous squamous cell carcinoma (SCC). It also focused on chronic acid reflux related diseases, including esophageal cancer.
Ticker SymbolCSTL
CompanyCastle Biosciences Inc
CEOMaetzold (Derek J)
Websitehttps://castlebiosciences.com/
Shareholders
Related Instruments
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Castle Biosciences Inc (CSTL)?
The current price of Castle Biosciences Inc (CSTL) is 28.09.
What is the symbol of Castle Biosciences Inc?
The ticker symbol of Castle Biosciences Inc is CSTL.
What is the 52-week high of Castle Biosciences Inc?
The 52-week high of Castle Biosciences Inc is 44.28.
What is the 52-week low of Castle Biosciences Inc?
The 52-week low of Castle Biosciences Inc is 14.59.
What is the market capitalization of Castle Biosciences Inc?
The market capitalization of Castle Biosciences Inc is 856.98M.
Is Castle Biosciences Inc (CSTL) currently rated as Buy, Hold, or Sell?
According to analysts, Castle Biosciences Inc (CSTL) has an overall rating of STRONG BUY, with a price target of 42.78.
What is the Earnings Per Share (EPS TTM) of Castle Biosciences Inc (CSTL)?
The Earnings Per Share (EPS TTM) of Castle Biosciences Inc (CSTL) is -0.83.